Hyperinsulinaemic hypoglycaemia in infancy and childhood - Resolving the enigma

Journal of Pediatric Endocrinology and Metabolism

Volumn 17, Issue 10, 2004, Pages 1375-1384

  Hussain, K ^a   Aynsley Green, A ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Glucose; Hyperinsulinism; Hypoglycaemia; Insulin; KATP channels

Indexed keywords

3 HYDROXYACYL COENZYME A DEHYDROGENASE; 3 HYDROXYBUTYRIC ACID; CHLOROTHIAZIDE; DIAZOXIDE; FATTY ACID; FLUORINE 18; GLUCAGON; GLUCOKINASE; GLUCOSE; GLUTAMATE DEHYDROGENASE; INSULIN; NIFEDIPINE; OCTREOTIDE; POTASSIUM CHANNEL; SOMATOMEDIN BINDING PROTEIN 1; TOLBUTAMIDE;

BIOCHEMISTRY; BLOOD ANALYSIS; BRAIN FUNCTION; CHILD CARE; CHILDHOOD; CLINICAL FEATURE; COOPERATION; DISEASE SEVERITY; ENDOCRINOLOGY; EUROPEAN UNION; FINANCIAL MANAGEMENT; GENE MUTATION; HUMAN; HYPERINSULINEMIA; HYPOGLYCEMIA; INFANCY; INSULIN RELEASE; INSULINOMA; MEDICAL RESEARCH; MEDICAL SOCIETY; MEMBRANE ELECTROPHYSIOLOGY; MOLECULAR BIOLOGY; NONHUMAN; PANCREAS ISLET; PATHOGENESIS; PATHOLOGICAL ANATOMY; PATHOPHYSIOLOGY; PORTAL VEIN; POSITRON EMISSION TOMOGRAPHY; REVIEW; SWINE;

EID: 7244226314     PISSN: 0334018X     EISSN: None     Source Type: Journal    
DOI: 10.1515/JPEM.2004.17.10.1375     Document Type: Review

References (65)

1. Laidlaw GF. Nesidioblastoma, the islet tumor of the pancreas. Am J Pathol 1938; 14: 125-134.
2. Rahier J, Guiot Y, Sempoux C. Persistent hyperinsulinaemic hypoglycaemia of infancy: a heterogeneous syndrome unrelated to nesidioblastosis. Arch Dis Child Fetal Neonatal Ed 2002; 82: F108-112.
3. De Lonlay P, Fournet JC, Touati G, Groos MS, Martin D, Sevin C, Delagne V, Mayaud C, Chigot V, Sempoux C, Brusset MC, Laborde K, Bellane-Chantelot C, Vassault A, Rahier J, Junien C, Brunelle F, Nihoul-Fekete C, Saudubray JM, Robert JJ. Heterogeneity of persistent hyperinsulinaemic hypoglycaemia. A series of 175 cases. Eur J Pediatr 2002; 161: 37-48.
4. Brunelle F, Negre V, Barth MO, Fekete CN, Czernichow P, Saudubray JM, Kuntz F, Tach T, l'Allemand D. Pancreatic venous samplings in infants and children with primary hyperinsulinism. Pediatr Radiol 1989; 19: 100-103.
5. de Lonlay-Debeney P, Poggi-Travert F, Fournet JC, Sempoux C, Vici CD, Brunelle F, Touati G, Rahier J, Junien C, Nihoul-Fekete C, Robert JJ, Saudubray JM. Clinical features of 52 neonates with hyperinsulinism. N Engl J Med 1999; 340; 1169-1175.
6. Thomas PM, Cote GJ, Wohllk N, Haddad B, Mathew PM, Rabl W, Aguilar-Bryan L, Gagel RF, Bryan J. Mutations in the sulfonylurea receptor gene in familial persistent hyperinsulinemic hypoglycemia of infancy. Science 1995; 268: 426-429.
7. Nestorowicz A, Wilson BA, Schoor KP, Inoue H, Glaser B, Landau H, Stanley CA, Thornton PS, Clement JP 4th, Bryan J, Aguilar-Bryan L, Permutt MA. Mutations in the sulphonylurea receptor gene are associated with familial hyperinsulinism in Ashkenazi Jews. Hum Mol Genet 1996; 5: 1813-1822.
8. Glaser B, Kesavan P, Heyman M, Davis E, Cuesta A, Buchs A, Stanley CA, Thornton PS, Permutt MA, Matschinsky FM, Herold KC. Familial hyperinsulinism caused by activating glucokinase mutation. N Engl J Med 1998; 338: 226-230.
9. Stanley CA, Lieu YK, Hsu BY, Burlina AB, Greenberg CR, Hopwood NJ, Perlman K, Rich BH, Zammarchi E, Poncz M. Hyperinsulinism and hyperammonemia in infants with regulatory mutations of the glutamate dehydrogenase gene. N Engl J Med 1998; 338: 1352-1357.
10. Clayton PT, Eaton S, Aynsley-Green A, Edginton M, Hussain K, Krywawych S, Datta V, Malingre HE, Berger R, van den Berg IE. Hyperinsulinism in shortchain L-3-hydroxyacyl-CoA dehydrogenase deficiency reveals the importance of beta-oxidation in insulin secretion. J Clin Invest 2001; 108: 457-465.
11. Matschinsky FM. A lesson in metabolic regulation inspired by the glucokinase glucose sensor paradigm. Diabetes 1996; 45: 223-227.
12. Malaisse WJ, Sener A, Herchuelz, Hutton JC. Insulin release: the fuel hypothesis. Metabolism 1979; 28: 373-386.
13. Dunne MJ, Peterson OH. Potassium selective ion channels in insulin-secreting cells: physiology, pharmacology and their role in stimulus-secretion coupling. Biochim Biophys Acta 1991; 1071: 67-82.
14. ATP: an inward rectifier subunit plus the sulfonylurea receptor. Science 1995; 270: 1166-1170.
15. + channel-dependent glucose action in rat pancreatic β-cell. Am J Physiol 1994; 266: C622-627.
16. + channels in mouse β-cells. J Clin Invest 1993; 91: 871-880.
17. ATP channel-independent pathways. Diabetes 2001; 50: 329-339.
18. Ammala C, Eliasson L, Bokvist K, Berggren PO, Honkanen RE, Sjoholm A, Rorsman P. Activation of protein kinases and inhibition of protein phosphatases play a central role in the regulation of exocytosis in mouse pancreatic β-cells. Proc Natl Acad Sci USA 1994; 91: 4343-4347.
19. Yajima H, Komatsu M, Schermerhorn T. cAMP enhances insulin secretion by an action on the ATP sensitive channel-independent pathway of glucose signalling in rat pancreatic islets. Diabetes 1999; 48: 1006-1012.
20. Macfarlane WM, McKinnon CM, Felton-Edkins ZA, Cragg H, James RF, Docherty K. Glucose stimulates translocation of the homeodomain transcription factor PDX-1 from the cytoplasm to the nucleus in pancreatic beta-cells. J Biol Chem 1999; 274: 1011-1016.
21. 2+. Diabetes 2000; 49: 418-423.
22. Melloul D, Ben-Neriah Y, Cerasi E. Glucose modulates the binding of an islet-specific factor to a conserved sequence within the rat I and the human insulin promoter. Proc Natl Acad Sci USA 1993; 90: 3865-3869.
23. Shepherd RM, Cosgrove KE, O'Brien RE, Barnes PD, Ammala C, Dunne MJ. Hyperinsulinism of infancy: towards an understanding of unregulated insulin release. European Network for Research into Hyperinsulinism in Infancy. Arch Dis Child Fetal Neonatal Ed 2000; 82: F87-97.
24. Aynsley-Green A, Polak JM, Bloom SR, Gough MH, Keeling J, Ashcroft SH. Nesidioblastosis of the pancreas: definition of the syndrome and the management of the severe neonatal hyperinsulinaemic hypoglycaemia. Arch Dis Childhood 1982; 56: 496-598.
25. Aynsley-Green A, Hussain K, Hall J, Saudubray JM, Nihoul-Fékété C, De Lonlay-Debeney P, Brunelle F, Otonkoski T, Thornton P, Lindley JK. The practical management of hyperinsulinism in infancy. Arch Dis Child Fetal Neonatal Ed 2000; 82: F98-107.
26. Dunne MJ, Cosgrove KE, Shepherd RM, Aynsley-Green A, Lindley KJ. Hyperinsulinism in infancy: from basic science to clinical disease. Physiol Rev 2004; 84: 239-275.
27. Cosgrove KE, Shepherd RM, Fernandez EM, Natarajan A, Lindley KJ, Aynsley-Green A, Dunne MJ. genetics and pathophysiology of hyperinsulinism in infancy. Horm Res 2004; 61: 270-288.
28. ATP channels in β-cells causes persistent hyperinsulinaemic hypoglycaemia of infancy. Nature Med 1996; 2: 1344-1347.
29. Glaser B, Thornton P, Otonkoski T, Junien C. Genetics of neonatal hyperinsulinism. Arch Dis Child Fetal Neonatal Ed 2000; 82: F79-86.
30. ATP channels. J Biol Chem 1999; 274: 20628-20632.
31. Partridge CJ, Beech DJ, Sivaprasadarao A. Identification and pharmacological correction of a membrane trafficking defect associated with a mutation in the sulfonylurea receptor causing familial hyperinsulinism. J Biol Chem 2001; 276: 35947-35952.
32. Cochrane WA, Payne WW, Simpkiss MJ, Woolf LI. Familial hypoglycemia precipitated by amino acids. J Clin Invest 1955; 35: 411-422.
33. Otonkoski T, Kaminen N, Ustinov J, Lapatto R, Meissner T, Mayatepek E, Kere J, Sipila I. Physical exercise-induced hyperinsulinemic hypoglycemia is an autosomal-dominant trait characterized by abnormal pyruvate-induced insulin release. Diabetes 2003; 52: 199-204.
34. De Lonlay P, Fournet JC, Rahier J, Gross-Morand MS, Poggi-Travert F, Foussier V, Bonnefont JP, Brusset MC, Brunelle F, Robert JJ, Nihoul-Fekete C, Saudubray JM, Junien C. Somatic deletion of the imprinted 11p15 region in sporadic persistent hyperinsulinemic hypoglycemia of infancy is specific of focal adenomatous hyperplasia and endorses partial pancreatectomy. J Clin Invest 1997; 100: 802-807.
35. Verkarre V, Fournet JC, Delonlay P. Paternal mutation of the sulphonylurea receptor (SUR 1) gene and maternal loss of the 11p15 imprinted genes lead to persistent hyperinsulinism in focal adenomatous hyperplasia. J Clin Invest 1998; 102: 1286-1291.
36. Ryan F, Devaney D, Joyce C, Nestorowicz A, Permutt MA, Glaser B, Barton DE, Thornton PS. Hyperinsulinism: molecular aetiology of focal disease. Arch Dis Child 1998; 79: 445-447.
37. Fournet JC, Mayaud C, de Lonlay P, Gross-Morand MS, Verkarre V, Castanet M, Devillers M, Rahier J, Brunelle F, Robert JJ, Nihoul-Fekete C, Saudubray JM, Junien C. Unbalanced expression of 11p15 imprinted genes in focal forms of congenital hyperinsulinism: association with a reduction to homozygosity of a mutation in ABCC8 or KCNJ11. Am J Pathol 2001; 158: 2177-2184.
38. Hussain K, Aynsley-Green A. Management of hyperinsulinism in infancy and childhood. Ann Med 2000; 32: 544-551.
39. Collins JE, Leonard JV, Teale D, Marks V, Williams DM, Kennedy CR, Hall MA. Hyperinsulinaemic hypoglycaemia in small for dates babies. Arch Dis Child 1990; 65: 1118-1120.
40. Collins JE, Leonard JV. Hyperinsulinism in asphyxiated and small for dates infants with hypoglycaemia. Lancet 1984; ii: 311-313.
41. Hussain K, Aynsley-Green A. Hyperinsulinaemic hypoglycaemia in preterm neonates. Arch Dis Child Fetal Neonatal Ed 2004; 89: F65-67.
42. Levitt-Katz LE, Satin-Smith M, Collet-Solberg P, Thornton PS, Baker L, Stanley CA, Cohen P. Insulin like growth factor binding protein-1 levels in the diagnosis of hypoglycaemia caused by hyperinsulinism. J Pediatr 1997; 131: 193-199.
43. Finegold DN, Stanely CA, Baker L. Glycaemic response to glucagon during fasting hypoglycaemia: an aid in the diagnosis of hyperinsulinism. J Pediatr 1980; 96: 257.
44. Barnes PD, O'Brien RE, Cosgrove KE, Abdel-Wahab YHA, Flatt PR, Aynsley-Green A, Dunne MJ. The hyperglycaemic effects of hydrochlorothiazide involve activation of potassium channels in insulin secreting cells. Arch Dis Child 2000; 82 (Suppl 1): P24.
45. Lindley KJ, Dunne MJ, Kane C, Shepherd RM, Squires PE, James RFL, Johnson PRV, Eckhardt S, Wakeling E, Milla PJ, Aynsley-Green A. Ionic control of the β-cell function in nesidioblastosis, a possible role for calcium channel blockade. Arch Dis Child 1996; 74: 373-378.
46. Abernethy LT, Davidson DC, Lamont GL, Shepherd RM, Dunne MJ. Intra-arterial calcium stimulation test in the investigation of hyperinsulinaemic hypoglycaemia. Arch Dis Child 1998; 78: 359-363.
47. Grimberg A, Ferry RJ Jr, Kelly A, Koo-McCoy S, Polonsky S, Glaser B, Permutt MA, Aguilar-Bryan L, Stafford D, Thornton PS, Baker L, Stanley CA. Dysregulation of insulin secretion in children with congenital hyperinsulinism due to sulfonylurea receptor mutations. Diabetes 2001; 50: 322-328.
48. Huopio H, Jaaskelainen J, Komulainen J, Miettinen R, Karkkainen P, Laakso M, Tapanainen P, Voutilainen R, Otonkoski T. Acute insulin response tests for the differential diagnosis of congenital hyperinsulinism. J Clin Endocrinol Metab 2002; 87: 4502-4507.
49. Stanley CA, Thornton PS, Ganguly A, MacMullen C, Underwood P, Bhatia P, Steinkrauss L, Wanner L, Kaye R, Ruchelli E, Suchi M, Adzick NS. Preoperative evaluation of infants with focal or diffuse congenital hyperinsulinism by intravenous acute insulin response tests and selective pancreatic arterial calcium stimulation. J Clin Endocrinol Metab 2004; 89: 288-296.
50. 18F-fluoro-L-Dopa PET. Horm Res 2003; 60 (Suppl 2): P2.
51. Lindley KJ, Knafelz D, St Louis D, Dunne MJ, Aynsley-Green A, Milla PJ. Surface electrogastrographic evidence of foregut dysmotility in persistent hyperinsulinaemic hypoglycaemia of infancy (PHHI). J Physiol (Lond) 1997; 499: 108.
52. Cryer PE. Regulation of glucose metabolism in man. J Intern Med 1991; 229 (Suppl 2): 31-39.
53. Auer RN, Siejo BK. Hypoglycaemia: brain neurochemistry and neuropathy. Clin Endocrinol Metab 1993; 7: 611-625.
54. McGowan JE, Ballesteros JR, Wei W, Zhu A. Pediatr Res 2000; 47; 291A.
55. Amiel SA, Archibald HR, Chusney G, Williams AJ, Gale EA. Ketone infusion lowers hormonal responses to hypoglycaemia: evidence for acute utilisation of a non-glucose fuel. Clin Sci 1991; 81: 189-194.
56. Jones MD. Energy metabolism in the developing brain. Semin Perinatol 1979; 3: 121-129.
57. Edmond J, Auestad N, Robbins RA, Bergstrom JD. Ketone body metabolism in the neonate: developmental and the effect of diet. Fed Proc 1985; 44: 2359-2364.
58. Plecko B, Stoekler-Ipsiroglu S, Schober E, Harrer G, Mlynarik V, Gruber S, Moser E, Moeslinger D, Silgoner H, Ipsiroglu O. Oral beta-hydroxybutyrate supplementation in two patients with hyperinsulinaemic hypoglycaemia: monitoring of beta-hydroxybutyrate levels in blood and cerebrospinal fluid, and the brain by in vivo magnetic resonance spectroscopy. Pediatr Res 2002; 52: 301-306.
59. Biggers DW, Myers SR, Neal D, Stinson R, Cooper NB, Jaspan JB, Williams PE, Cherrington AD, Frizzell RT. Role of brain in counter-regulation of insulin-induced hypoglycaemia in dogs. Diabetes 1989; 38: 7-16.
60. Borg WP, During MJ, Sherwin RS, Borg MA, Brines ML, Shulman GI. Ventromedial hypothalamus lesions in rats suppress counter-regulatory hormone responses to hypoglycaemia. J Clin Invest 1994; 96: 1677-1688.
61. Silver IA, Erecinska M. Glucose-induced intracellular ion changes in sugar-sensitive hypothalamic neurons. J Neurophysiol 1998; 79: 1733-1745.
62. Yang XJ, Kow LM, Funabashi T, Mobbs CV. Hypothalamic glucose sensor: similarities to and differences from the pancreatic β-cell mechanism. Diabetes 1999; 48: 1763-1772.
63. Baskin DG, Figlewicz DP, Woods SC, Porte D Jr, Dorsa DM. Insulin in the brain. Annu Rev Physiol 1987; 49: 56-59.
64. Corp ES, Woods SC, Porte D, Dorsa DM, Figlewicz DP, Baskin DG. Localisation of insulin binding sites in the rat hypothalamus by quantitative autoradiography. Neurosci Lett 1986; 79: 17-22.
65. Plagemann A, Harder T, Rake A, Janert U, Melchior K, Rohde W, Dorner G. Morphological alterations of hypothalamic nuclei due to intrahypothalamic hyperinsulinism in newborn rats. Int J Dev Neurosci 1999; 17: 37-44.